# AbCellera Posts $10.6 Million in Q3 2026 Revenue, $0.13 Net Loss Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/53382
Published: 2026-11-10T23:04:44.000Z
Updated: 2026-11-10T23:04:44.000Z
Section: Business

> The net loss was $0.13 per share on both a basic and diluted basis. AbCellera released its results Nov. 9.

AbCellera Biologics Inc. posted $10.6 million in revenue and a net loss of $0.13 per share for Q3 2026, the two headline figures in its latest quarterly results.

The per-share loss was $0.13 on both a basic and diluted basis. AbCellera released its Q3 2026 results Nov. 9.